544759 — Goldline Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹288.96m
- IN₹374.65m
- IN₹311.98m
Annual cashflow statement for Goldline Pharmaceutical, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 4.01 | 25.2 | 38.6 | 53.9 |
| Depreciation | ||||
| Non-Cash Items | 18.2 | 16.5 | 18.1 | 13.2 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.072 | -14.2 | -36 | -41.3 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 23.9 | 29.2 | 23.2 | 28.1 |
| Capital Expenditures | -11.1 | -11.1 | -2.07 | -0.567 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0.733 | 0 | 3.69 | -0.011 |
| Sale of Fixed Assets | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -10.3 | -11.1 | 1.62 | -0.578 |
| Financing Cash Flow Items | -16.2 | -14.6 | -17.2 | -13.1 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -14.4 | -10.8 | -20.3 | -34 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.868 | 7.36 | 4.5 | -6.47 |